Macquarie Group LTD Compugen LTD Transaction History
Macquarie Group LTD
- $80.3 Billion
- Q1 2025
A detailed history of Macquarie Group LTD transactions in Compugen LTD stock. As of the latest transaction made, Macquarie Group LTD holds 1,020,000 shares of CGEN stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,020,000
Previous 1,020,000
-0.0%
Holding current value
$1.5 Million
Previous $1.56 Million
4.55%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CGEN
# of Institutions
79Shares Held
16.3MCall Options Held
28.7KPut Options Held
48.3K-
Silverarc Capital Management, LLC2.9MShares$4.26 Million1.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.4MShares$2.05 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.39MShares$2.04 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.05MShares$1.54 Million0.94% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD990KShares$1.46 Million0.09% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $127M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...